You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., May 9, 2019 /PRNewswire/ -- Astellas is proud to announce that Chelsea Glinski, executive director, Reimbursement Strategy will be recognized by the Healthcare Businesswomen's Association (HBA) as a 2019 Luminary during the 30th Annual HBA Woman of the Year Awards Ceremony for the contributions she's made towards improving the lives of patients throughout her career.
Held in New York City, the event celebrates excellence in leadership among healthcare and life science industry leaders. HBA Luminaries are industry veterans and strong role models in their company who actively mentor and sponsor others helping to advance the careers of businesswomen.
"Chelsea's deep passion for helping patients, rich industry background and proven leadership style make her a natural choice for the HBA Luminary recognition," said Shontelle Dodson, senior vice president, Health Systems. "Chelsea is a role model at Astellas, not only leading the work to support greater patient access to treatments, but also demonstrating how a woman can successfully drive her career forward while continuing to be a devoted mother."
Early in her career, Chelsea spent time in neuropsychopharmacology research supporting discovery of novel treatments for schizophrenia and depression. She combined her love of science with a Master's in Business Administration transitioning into strategy and management consulting for the Life Sciences sector. It was following this experience that Chelsea joined Astellas, first in a role supporting strategy and operations for the Health Systems business unit and most recently leading the Market Access & Reimbursement Strategy function overseeing patient support and access programs.
"I've had many meaningful experiences in my career, but advancing patient access to Astellas medicines to improve their quality of life has been the most rewarding," said Glinski. "I'm so honored to be an HBA Luminary and humbled to be in the company of so many amazing women."
Chelsea credits perseverance and having strong female mentors with helping her make the bold jump from research to client-facing support roles. Through her work with Astellas' Stellar Women Employee Resource Group, she pays this forward by actively coaching and supporting other women to create an environment of empowerment and advocacy that helps advance and inspire women at Astellas.
About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.com/us. You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.
About the HBA
The Healthcare Businesswomen's Association (HBA) is a global not-for-profit organization dedicated to furthering the advancement and impact of women in the business of healthcare. With more than 50 locations throughout the United States, Europe and Canada, the HBA serves a community of nearly 50,000 individuals and more than 140 corporate partners. The HBA provides networking forums; access to industry thought leaders; educational programs to develop leadership skills and global recognition of outstanding women and companies advancing gender parity in the workplace.
SOURCE Astellas
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.